Compounds > methotrexate
Page last updated: 2024-08-25

methotrexate and Neuropathy, Subacute Combined Degeneration

methotrexate has been researched along with Neuropathy, Subacute Combined Degeneration in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's6 (85.71)24.3611
2020's1 (14.29)2.80

Authors

AuthorsStudies
Duarte, FB; Lima, TT; Nóbrega, PR; Rodrigues, PGB1
Cardemil, D; Cartier R, L; Parra V, J; Puga, B1
Madaan, P; Saini, L1
Matsuo, M; Nakamura, T1
Diong, CP; Gosavi, T; Lim, SH1
Hosoya, Y; Kumagai, MA; Matsuoka, K; Mori, T; Morishita, Y; Nakazawa, A; Noguchi, M; Okita, H; Satomi, K; Shioda, Y; Yoshida, M1
Cachia, D; Chi, L; Cykowski, MD; Dabaja, BS; Daver, N; Dinardo, C; Fuller, G; Garg, N; Jabbour, EJ; Jain, N; Kadia, TM; Kamiya-Matsuoka, C; Kantarjian, HM; Konopleva, M; Milgrom, SA; Ohanian, M; Pemmaraju, N; Pinnix, CC; Smith, GL; Woodman, K1

Other Studies

7 other study(ies) available for methotrexate and Neuropathy, Subacute Combined Degeneration

ArticleYear
Myelopathy associated with intrathecal methotrexate.
    Practical neurology, 2022, Volume: 22, Issue:2

    Topics: Adult; Humans; Magnetic Resonance Imaging; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Spinal Cord Diseases; Subacute Combined Degeneration; Young Adult

2022
[Spinal subacute combined degeneration after intrathecal chemotherapy. Report of two cases].
    Revista medica de Chile, 2018, Volume: 146, Issue:6

    Topics: Adolescent; Antimetabolites, Antineoplastic; Cytarabine; Fatal Outcome; Female; Humans; Injections, Spinal; Magnetic Resonance Imaging; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Subacute Combined Degeneration

2018
Methotrexate myelopathy.
    Brain & development, 2019, Volume: 41, Issue:7

    Topics: Copper; Folic Acid; Humans; Methotrexate; Spinal Cord Diseases; Subacute Combined Degeneration

2019
Reply to the Letter, "Methotrexate myelopathy: A mimicker of subacute combined degeneration of the spinal cord".
    Brain & development, 2019, Volume: 41, Issue:7

    Topics: Copper; Folic Acid; Humans; Methotrexate; Spinal Cord; Spinal Cord Diseases; Subacute Combined Degeneration

2019
Methotrexate-induced myelopathy mimicking subacute combined degeneration of the spinal cord.
    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2013, Volume: 20, Issue:7

    Topics: Adult; Antimetabolites, Antineoplastic; Diagnosis, Differential; Female; Humans; Injections, Spinal; Magnetic Resonance Imaging; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Spinal Cord Diseases; Subacute Combined Degeneration

2013
Myelopathy mimicking subacute combined degeneration in a Down syndrome patient with methotrexate treatment for B lymphoblastic leukemia: report of an autopsy case.
    Neuropathology : official journal of the Japanese Society of Neuropathology, 2014, Volume: 34, Issue:4

    Topics: Antimetabolites, Antineoplastic; Down Syndrome; Female; Folic Acid Antagonists; Humans; Leukemia, B-Cell; Methotrexate; Spinal Cord Diseases; Subacute Combined Degeneration; Young Adult

2014
Dorsal column myelopathy after intrathecal chemotherapy for leukemia.
    American journal of hematology, 2017, Volume: 92, Issue:2

    Topics: Antimetabolites, Antineoplastic; Diagnosis, Differential; Electronic Health Records; Female; Folic Acid; Homocysteine; Humans; Injections, Spinal; Leukemia; Magnetic Resonance Imaging; Male; Methotrexate; Spinal Cord Diseases; Subacute Combined Degeneration

2017